XML 23 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents [1] $ 556,785 $ 437,577
Accounts receivable [1] 743,031 775,452
Inventories [1] 115,093 105,485
Prepaid expenses [1] 113,749 77,281
Other current assets [1] 304,093 222,290
Total current assets [1] 1,832,751 1,618,085
Assets, Noncurrent [Abstract]    
Property and equipment, net [1] 861,899 811,089
Goodwill [1] 852,084 844,704
Other intangible assets [1] 76,930 76,930
Deferred income taxes [1] 12,321 32,491
Other assets [1] 142,969 147,106
Total assets [1] 4,956,100 4,731,558
Current liabilities:    
Current installments of long-term debt [1] 9,234 18,605
Accounts payable [1] 401,249 474,543
Accrued salaries and benefits [1] 295,117 267,685
Other accrued expenses and liabilities [1] 239,824 233,271
Total current liabilities [1] 945,424 994,104
Liabilities, Noncurrent [Abstract]    
Long-term debt, less current maturities [1] 1,085,818 1,168,253
Long-term operating lease liability 1,140,756  
Self-insured liabilities [1] 227,048 243,552
Other long-term liabilities [1] 34,697 76,002
Total liabilities [1] 3,433,743 3,649,242
Commitments and contingencies [1]
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]    
Redeemable noncontrolling interests [1] 1,158 7,302
Common units, no and unlimited units authorized as of December 31, 2024 and December 31, 2023, respectively; no and 484,922,828 units issued and outstanding as of December 31, 2024 and December 31, 2023, respectively [1] 0 496,882
Preferred stock, par value $0.01 per share; 50,000,000 and no shares authorized as of December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of December 31, 2024 and December 31, 2023 [1] 0 0
Common stock, par value $0.01 per share; 750,000,000 and no shares authorized as of December 31, 2024 and December 31, 2023, respectively; 142,747,818 and no shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively [1] 1,428 0
Additional Paid in Capital [1] 754,415 0
Accumulated other comprehensive income [1] 9,737 18,561
Retained earnings [1] 365,796 155,453
Equity attributable to Ardent Health Partners, Inc. [1] 1,131,376 670,896
Noncontrolling interests [1] 389,823 404,118
Total equity [1] 1,521,199 1,075,014
Total liabilities and equity [1] 4,956,100 4,731,558
Nonrelated Party    
Assets, Noncurrent [Abstract]    
Operating lease right of use assets [1] 248,040 260,003
Liabilities, Noncurrent [Abstract]    
Long-term operating lease liability [1] 221,443 235,241
Related Party    
Assets, Noncurrent [Abstract]    
Operating lease right of use assets [1] 929,106 941,150
Liabilities, Noncurrent [Abstract]    
Long-term operating lease liability [1] $ 919,313 $ 932,090
[1] As of December 31, 2024 and December 31, 2023, the consolidated balance sheets included total liabilities of consolidated variable interest entities of $306.4 million and $337.8 million, respectively. Refer to Note 2 "Summary of Significant Accounting Policies" for further discussion.